) (100.0) Gain on disposals of investments in subsidiaries 58.8 1.8 - - (58.8) (100.0) Interest income 3.6 0.1 5.2 0.2 1.6 44.2 Other income 168.0 5.0 70.8 2.1 (97.3) (57.9) Total Revenues 3,336.5 100.0
% YoY Sales revenue 3,654 5,219 -30% 3,704 -1% 16,225 19,472 -17% EBITDA 286 387 -26% 289 -1% 923 1,138 -19% EBITDA Margin (%) 7.8% 7.4% 0.4% 7.8% 0% 5.7% 5.8% -0.1% Stock Gain/(Loss) & NRV -24 -62 -61
-31% EBITDA 88 137 -36% 141 -38% 229 348 -34% EBITDA Margin (%) 2.7% 3.2% -0.5% 5.1% -2.4% 3.8% 3.9% -0.1% Stock Gain/(Loss) & NRV -58 -149 -61% -74 -22% -132 -382 -65% Adjusted EBITDA(1) 146 286 -49
July 2018 with a gain from business combination of Baht 276 million which should be amortised by Baht 12 million per annum along the PPA life. BGRIM started to consolidate BGYSP’s financial statement in
-50% 273 637 -57% EBITDA Margin (%) 1.4% 7.8% -6.4% 2.7% -1.3% 3.0% 5.1% -2.1% Stock Gain/(Loss) & NRV 13 -57 -123% -58 -122% -119 -439 -73% Adjusted EBITDA(1) 31 346 -91% 146 -79% 392 1,076 -64
nine-month period ended 30 September, 2016 2017 2018 2018 2019 Amount (Baht) Amount (Baht) Amount (Baht) Amount (Baht) Amount (Baht) (in millions) Gain on credit for purchase of receivables1 1,232.3
Fund (“กองทุนหลัก”) หลักมีกลยุทธ์การลงทุนในตราสารทุนทั่ว โลกที่เกี่ยวกับบริษัทในอุตสาหกรรมการดูแลสุขภาพ (Healthcare Industry) และบริษัทในอุตสาหกรรมการดูแลสุขภาพที่เป็น นวัตกรรมในด้านต่าง ๆ (Innovative
% EBITDA margin (%) 27.3% 27.9% NNP margin (%) 9.7% 9.5% % NNP - Owner of the parent 58.6% 59.1% Remark: *Normalized net profit = Net profit – Unrealized gain (loss) from FX – Non-recurring income / (expense
increase the normal capacity during off peak power usage in 4th Quarter of 2017. - Gain from debt restructuring was achieved of THB 734 million some portion resulting from debt-to-equity conversion scheme in
for producing of HRC to increase the normal capacity during off peak power usage in 4th Quarter of 2017. - Gain from debt restructuring was achieved of THB 734 million some portion resulting from debt